Stocks and Investing
Stocks and Investing
Tue, September 1, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 31, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Morabito Maintained (VKTX) at Strong Buy with Increased Target to $20 on, Aug 31st, 2020
Michael Morabito of Chardan Capital, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $15 to $20 on, Aug 31st, 2020.
Michael has made no other calls on VKTX in the last 4 months.
There are 3 other peers that have a rating on VKTX. Out of the 3 peers that are also analyzing VKTX, 0 agree with Michael's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Michael
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $21 on, Friday, August 28th, 2020
- Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $14 on, Friday, June 5th, 2020
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $25 on, Friday, May 1st, 2020